TAM populations have also been implicated in determining sensitivity and resistance to immune checkpoint therapy in ccRCC15,16 and an interaction network between inflammatory macrophages, exhausted CD8 + T cells and presentation of tumour neoantigens has been shown to be predictive of response to immune checkpoint blockade17. The gene discussed is CD8A; the disease is neoplasm.